Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

10.22

-0.29 (-2.76%)

At close: Jul 24, 2026, 4:00 PM EDT

10.25

+0.03 (0.29%)

After-hours: Jul 24, 2026, 7:34 PM EDT

Telix Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	803.79	803.79	516.55	332.98	108.95	5.52
Revenue Growth	20.46%	55.61%	55.13%	205.64%	1873.24%	37.53%
Gross Profit	426.44	426.44	336.16	209.53	64.6	3.67
Operating Income	29.78	29.78	55.18	11.01	-62.56	-33.41
Net Income	-7.13	-7.13	33.69	4.21	-70.83	-58.52
Earnings Per Share	-0.02	-0.02	0.10	0.01	-0.22	-0.21
EPS Growth	-	-	674.20%	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024
Precision Medicine	621.93	621.93	508.51	329.21
Therapeutics	9.27	9.27	6.23	3.5
Manufacturing Solutions	245.11	245.11	1.82	0.28
Inter-Segment Elimination	-72.51	-72.51	-	-
Total	803.79	803.79	516.55	332.98

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	141.87	141.87	440	83.95	79.16	16.02
Total Debt	467.11	467.11	360.16	11.88	7.11	1.85
Net Cash (Debt)	-325.24	-325.24	79.84	72.07	72.05	14.17
Net Cash Growth	-	-	10.78%	0.02%	408.42%	-75.70%
Net Cash Per Share	-0.96	-0.96	0.24	0.22	0.23	0.05

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-34.59	-34.59	54.98	28.55	-43.53	-43.12
Capital Expenditures	-25.69	-25.69	-9.12	-6.31	-4.79	-0.97
Free Cash Flow	-60.28	-60.28	45.86	22.24	-48.32	-44.1
Free Cash Flow Growth	-	-	106.23%	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	53.05%	53.05%	65.08%	62.93%	59.29%	66.46%
Operating Margin	3.70%	3.70%	10.68%	3.31%	-57.42%	-605.17%
Pretax Margin	-0.66%	-0.66%	7.34%	0.78%	-61.60%	-1059.31%
Profit Margin	-0.89%	-0.89%	6.52%	1.26%	-65.01%	-1059.90%
FCF Margin	-7.50%	-7.50%	8.88%	6.68%	-44.35%	-798.67%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	153.03	-	-	-
P/FCF Ratio	-	-	112.40	-	-	-
PS Ratio	4.33	3.16	9.98	-	-	-